ELOXX PHARMACEUTICALS INC (ELOX) Forecast, Price Target & Analyst Ratings

NASDAQ:ELOX • US29014R2022

Current stock price

3.82 USD
-0.23 (-5.68%)
At close:
2.8 USD
-1.02 (-26.7%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ELOXX PHARMACEUTICALS INC (ELOX).

Forecast Snapshot

Consensus Price Target

Price Target
$61.20
+ 1,502.09% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 8, 2023
Period
Q3 / 2023
EPS Estimate
-$2.01
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.71%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$61.20
Upside
+ 1,502.09%
From current price of $3.82 to mean target of $61.20, Based on 7 analyst forecasts
Low
$60.60
Median
$61.20
High
$63.00

Price Target Revisions

1 Month
9.09%
3 Months
20.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for ELOX. The average price target is 61.2 USD. This implies a price increase of 1502.09% is expected in the next year compared to the current price of 3.82.
The average price target has been revised upward by 20% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ELOX Current Analyst RatingELOX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

ELOX Historical Analyst RatingsELOX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
85.71%
ELOX was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about ELOX.
In the previous month the buy percentage consensus was at a similar level.
ELOX was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-07-11OppenheimerMaintains Outperform -> Outperform
2023-04-06OppenheimerReiterate Outperform
2022-05-23Piper SandlerMaintains Overweight
2022-05-09HC Wainwright & Co.Maintains Neutral
2021-12-17OppenheimerInitiate Outperform
2021-11-18HC Wainwright & Co.Maintains Neutral
2021-11-11HC Wainwright & Co.Maintains Neutral
2021-06-30MizuhoInitiate Buy
2021-05-27B. Riley SecuritiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 8, 2023
Period
Q3 / 2023
EPS Estimate
-$2.01
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
44.18%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
-100.00%
EPS (1 Month)
0.00%
EPS (3 Months)
-4.23%

Next Earnings Summary

ELOX is expected to report earnings on 11/8/2023. The consensus EPS estimate for the next earnings is -2.01 USD and the consensus revenue estimate is 0 USD.
The next earnings revenue estimate has been revised downward by 100% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
ELOX revenue by date.ELOX revenue by date.
80K80KN/A
-100.00%		177.29M
EBITDA
YoY % growth
ELOX ebitda by date.ELOX ebitda by date.
-7.49M-5.32M
28.97%		N/A
11.65%		N/A
-894.89%		-44.982M
-7.93%		N/A
41.81%		N/A
-124.39%		N/A
47.89%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
ELOX ebit by date.ELOX ebit by date.
-7.67M-5.41M
29.47%		N/A
12.38%		-45.449M
-891.14%		-53.267M
-7.62%		-37.052M
41.77%		-66.408M
-124.25%		-35.7M
47.86%		-21.42M
37.77%		-28.56M
-33.33%		-43.86M
-53.57%		-56.1M
-27.91%		105.89M
288.75%
Operating Margin
ELOX operating margin by date.ELOX operating margin by date.
-9,587.50%-6,762.50%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A59.73%
EPS
YoY % growth
ELOX eps by date.ELOX eps by date.
N/AN/AN/A-57.15-55.87
2.90%		-37.74
47.01%		-38.35
5.63%		-16.97
38.36%		-8.07
51.16%		-7.54
6.57%		-6.78
10.01%		-8.20
-20.90%		14.15
272.51%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-2.01
44.18%		-1.46
50.05%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/A
EBIT
Q2Q % growth		-4.08M
42.87%		-4.975M
17.48%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ELOX Yearly Revenue VS EstimatesELOX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2027 50M 100M 150M
ELOX Yearly EPS VS EstimatesELOX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -20 -40

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
16.70%
EPS Next 5 Year
23.36%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ELOXX PHARMACEUTICALS INC / ELOX Forecast FAQ

What is the average price target for ELOXX PHARMACEUTICALS INC (ELOX) stock?

7 analysts have analysed ELOX and the average price target is 61.2 USD. This implies a price increase of 1502.09% is expected in the next year compared to the current price of 3.82.

Can you provide the upcoming earnings date for ELOXX PHARMACEUTICALS INC?

ELOXX PHARMACEUTICALS INC (ELOX) will report earnings on 2023-11-08, before the market open.

Can you provide the consensus estimates for ELOXX PHARMACEUTICALS INC next earnings?

The consensus EPS estimate for the next earnings of ELOXX PHARMACEUTICALS INC (ELOX) is -2.01 USD and the consensus revenue estimate is 0 USD.

Can you provide the consensus rating for ELOXX PHARMACEUTICALS INC stock?

The consensus rating for ELOXX PHARMACEUTICALS INC (ELOX) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.